RELAPSED/REFRACTORY B-CELL NON-HODGKIN LYMPHOMA OR CLL/SLL

Clinical trials for RELAPSED/REFRACTORY B-CELL NON-HODGKIN LYMPHOMA OR CLL/SLL explained in plain language.

Never miss a new study

Get alerted when new RELAPSED/REFRACTORY B-CELL NON-HODGKIN LYMPHOMA OR CLL/SLL trials appear

Sign up with your email to follow new studies for RELAPSED/REFRACTORY B-CELL NON-HODGKIN LYMPHOMA OR CLL/SLL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Double-Targeted immune cells take on Hard-to-Treat blood cancers

Disease control Recruiting now

This study is testing a new type of CAR-T cell therapy that targets two different markers on cancer cells at the same time. It is for adults with blood cancers like leukemia, lymphoma, or multiple myeloma that have come back or not responded to other treatments. The goal is to se…

Matched conditions: RELAPSED/REFRACTORY B-CELL NON-HODGKIN LYMPHOMA OR CLL/SLL

Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control

Last updated May 17, 2026 05:30 UTC

RELAPSED/REFRACTORY B-CELL NON-HODGKIN LYMPHOMA OR CLL/SLL

Get alerted when new RELAPSED/REFRACTORY B-CELL NON-HODGKIN LYMPHOMA OR CLL/SLL trials appear

Double-Targeted immune cells take on Hard-to-Treat blood cancers